SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-24-000029
Filing Date
2024-08-01
Accepted
2024-08-01 16:45:52
Documents
112
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20240630.htm   iXBRL 10-Q 2714059
2 EX-10.2 exhibit102-employeematters.htm EX-10.2 319790
3 EX-31.1 exhibit311q22024.htm EX-31.1 10086
4 EX-31.2 exhibit312q22024.htm EX-31.2 10166
5 EX-32.1 exhibit321q22024.htm EX-32.1 6569
6 EX-32.2 exhibit322q22024.htm EX-32.2 6717
  Complete submission text file 0000885590-24-000029.txt   13619946

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20240630.xsd EX-101.SCH 97090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20240630_cal.xml EX-101.CAL 91410
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20240630_def.xml EX-101.DEF 544285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20240630_lab.xml EX-101.LAB 875059
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20240630_pre.xml EX-101.PRE 721320
115 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20240630_htm.xml XML 2383792
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 241167481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)